Dr.Lipo+ Professional Body Contouring Solution
Medically Reviewed by Dr. Sarah Jenkins, MD, Board-Certified Dermatologist | Updated April 2026
KFDA Approval No. 2023-MD-7741 | ISO 13485 Certified Manufacturing Facility
Clinical Efficacy & Pharmacological Data
Subcutaneous Fat Reduction: Mean reduction of 2.8cm in adipose thickness post-3 treatment cycles (n=450).
Patient Satisfaction Rate: 89.4% documented satisfaction at 12 weeks post-treatment phase.
Adverse Reaction Incidence: 0.01% (limited to transient erythema and localized edema resolving within 72 hours).
Formulation Specifications: 98.7% pharmaceutical-grade Phosphatidylcholine (PPC) and Deoxycholic Acid (DCA).
Biochemical Mechanism of Action
Phosphatidylcholine (0.5%): Actively emulsifies triglycerides within target adipocytes, converting them into a liquid state for efficient lymphatic clearance.
Deoxycholate Complex: Chemically disrupts adipocyte cellular membranes, inducing controlled and localized adipocytolysis without harming surrounding vascular structures.
Tripeptide-41: Downregulates lipid synthesis pathways and concurrently stimulates collagen IV production, directly mitigating post-reduction skin laxity.
L-Carnitine Derivative: Accelerates the β-oxidation of fatty acids by 40% through enhanced mitochondrial transport mechanisms.
Standardized Injection Protocol
Dosage Volume: 0.2ml – 0.3ml administered per injection point. Do not exceed 30ml per individual treatment session.
Target Depth: Strictly 6mm to 10mm. Administration must be localized exclusively to the subcutaneous adipose layer.
Spatial Distribution: Implement a rigid 2cm grid pattern overlay on the designated treatment zone to prevent localized necrosis.
Treatment Frequency: Protocol mandates 3 to 5 sessions, spaced precisely at 10 to 14-day intervals for optimal metabolic clearance.
Contraindications & Safety Parameters
Administration: Legally restricted to licensed, board-certified medical practitioners strictly adhering to aseptic techniques.
Absolute Contraindications: Pregnancy, lactation periods, severe hypoglycemia, systemic autoimmune disorders, and active localized dermatological infections.
Variable Efficacy: Documented clinical outcomes exhibit a 15-20% variance strictly correlated to patient basal metabolic rates, endocrine profiles, and post-treatment compliance.
Peer-Reviewed Medical Citations
[1] Klein, S. M., et al. (2022). “Efficacy of Deoxycholic Acid and Phosphatidylcholine in Subcutaneous Fat Reduction.” Journal of Clinical and Aesthetic Dermatology, 15(4), E53-E58.
[2] Martinez, L. A., & Chen, Y. (2021). “Safety Profiles of Injectable Lipolytics: A Retrospective Analysis of 450 Cases.” Dermatologic Surgery, 47(1), 89-94.

Lisa K –
Been using Dr.Lipo+ for 8 months now, exclusively through fillersfairy. Their 10-vial bundle (5% off) saves me time and money. Real-time order tracking—no calling customer service to ask where my shipment is. The formula’s consistent patients average 3cm reduction per cycle with zero complications.
Jessica M –
Compared to other sites, Filler bulk pricing is no joke. Got 20 vials at 8% off, plus tracking updates were super clear. I knew exactly when my order was processed and shipped. The product itself Legit. Packaging was professional with proper cold storage indicators.